Cargando…
Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors
BACKGROUND: This study was conducted to assess the adverse reactions caused by multi‐target tyrosine kinase inhibitor treatment of gastrointestinal tumors. METHODS: We carried out a retrospective study of drug‐related adverse reactions in 115 patients who were treated with sorafenib, sunitinib, and...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928375/ https://www.ncbi.nlm.nih.gov/pubmed/29575544 http://dx.doi.org/10.1111/1759-7714.12608 |